Literature DB >> 11403060

Riluzole for motor neurone disease. More trials are needed.

J Sandercock, A Burls, C Hyde, A Fry-Smith, P Barton, S Bryan, A Stewart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11403060      PMCID: PMC1120391     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  NICE approves drugs for Alzheimer's disease.

Authors:  Z Kmietowicz
Journal:  BMJ       Date:  2001-01-27

Review 2.  The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review.

Authors:  A Stewart; J Sandercock; S Bryan; C Hyde; P M Barton; A Fry-Smith; A Burls
Journal:  Health Technol Assess       Date:  2001       Impact factor: 4.014

3.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.

Authors:  D A Snowdon; L H Greiner; J A Mortimer; K P Riley; P A Greiner; W R Markesbery
Journal:  JAMA       Date:  1997-03-12       Impact factor: 56.272

4.  Ethnic differences in incidence of stroke: prospective study with stroke register.

Authors:  J A Stewart; R Dundas; R S Howard; A G Rudd; C D Wolfe
Journal:  BMJ       Date:  1999-04-10

5.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

  5 in total
  2 in total

1.  Riluzole for motor neurone disease. Reply from chairman of appraisal committee at NICE.

Authors:  D Barnett
Journal:  BMJ       Date:  2001-09-08

2.  Neuropsychotherapeutics in the UK: what has been the impact of NICE on prescribing?

Authors:  Tom Walley
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.